Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 90% above its 5-year average of 52.63%, near the high end of its 5-year range (-1513500.00%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. In line with its 12-month average of 100.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
100.00%
GROSS MARGIN AVG 3Y
100.00%
GROSS MARGIN AVG 5Y
52.63%
GROSS MARGIN AVG 10Y
-182.20%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
0.00%
CURRENT VS 3Y AVG
0.00%
CURRENT VS 5Y AVG
+90.00%
CURRENT VS 10Y AVG
+154.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
38.44%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
+160.15%
vs the sector median at left
AC Immune S.A.
Market Cap
$260.03M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
52.63%
Market Cap
$262.11M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
16.67%
Market Cap
$263.39M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1258.31%
5Y Avg
-887.92%
Market Cap
$258.56M
Gross Margin
62.16%
TTM Avg
59.97%
3Y Avg
63.15%
5Y Avg
60.27%
Market Cap
$264.62M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$256.22M
Gross Margin
88.00%
TTM Avg
94.00%
3Y Avg
97.00%
5Y Avg
64.67%
Market Cap
$267.17M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$267.82M
Gross Margin
41.38%
TTM Avg
41.46%
3Y Avg
41.37%
5Y Avg
45.85%
Market Cap
$271.23M
Gross Margin
93.41%
TTM Avg
92.41%
3Y Avg
88.66%
5Y Avg
85.93%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AC Immune S.A. (ACIU) | $260.03M | 100.00% | 100.00% | 100.00% | 52.63% |
| Palisade Bio, Inc. (PALI)vs › | $262.11M | 0.00% | 0.00% | 25.00% | 16.67% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.39M | 0.00% | 0.00% | -1258.31% | -887.92% |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.56M | 62.16% | 59.97% | 63.15% | 60.27% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $264.62M | 0.00% | 0.00% | 25.00% | 50.00% |
| Century Therapeutics, Inc. (IPSC)vs › | $256.22M | 88.00% | 94.00% | 97.00% | 64.67% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $267.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| OraSure Technologies, Inc. (OSUR)vs › | $267.82M | 41.38% | 41.46% | 41.37% | 45.85% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $271.23M | 93.41% | 92.41% | 88.66% | 85.93% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $249.41M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 100.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -1513500.00% |
| 2022-09-30 | -265.66% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -1589.72% |
| 2020-09-30 | -1281.83% |
| 2020-06-30 | -1082.73% |
| 2020-03-31 | -23.84% |
| 2019-12-31 | -1604.88% |
| 2019-09-30 | 65.65% |
| 2019-06-30 | -740.50% |
| 2019-03-31 | 84.55% |
| 2018-12-31 | -764.36% |
| 2018-09-30 | -400.91% |
| 2018-06-30 | -419.38% |
| 2018-03-31 | -590.60% |
| 2017-12-31 | 38.16% |
| 2017-09-30 | -663.04% |
| 2017-06-30 | -808.10% |
| 2017-03-31 | -271.59% |
| 2016-12-31 | -393.71% |
| 2016-09-30 | -477.34% |
| 2016-06-30 | 71.72% |
| 2016-03-31 | -1003.08% |
| 2015-12-31 | -1710.48% |
| 2015-09-30 | 82.95% |
| 2015-06-30 | 68.56% |
| 2015-03-31 | -1064.26% |
| 2014-12-31 | 80.42% |
| 2014-09-30 | -1935.64% |
| 2014-06-30 | -77.19% |
| 2014-03-31 | -77.19% |
